Clinical Trial Update: Human Chorionic Gonadotrophin & Trigger [Phase 3]

View source ↗

Summary

Phase 3 trial update studying human chorionic gonadotropin with a trigger for ovulation disorders; sponsor Cairo University; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovulation Disorders

Drugs mentioned

• Gonadotropin-releasing hormone agonist
• Human chorionic gonadotropin (human chorionic gonadotropin)

Snippet

Sponsor: Cairo University | Conditions: Ovulation Disorder | Phase 3 | Status: UNKNOWN